| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.05 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.085 | 0.05 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.062 | 0.05 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.089 | 0.05 |
| mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | -0.083 | 0.05 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.05 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.05 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.05 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.07 | 0.05 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.05 |